ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 174 filers reported holding ACCELERON PHARMA INC in Q1 2019. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,721,000 | +37.1% | 10,000 | 0.0% | 0.23% | +40.1% |
| Q2 2021 | $1,255,000 | -7.5% | 10,000 | 0.0% | 0.17% | -13.5% |
| Q1 2021 | $1,357,000 | +6.1% | 10,000 | 0.0% | 0.19% | -2.0% |
| Q4 2020 | $1,279,000 | +13.7% | 10,000 | 0.0% | 0.20% | -2.5% |
| Q3 2020 | $1,125,000 | +18.2% | 10,000 | 0.0% | 0.20% | +12.8% |
| Q2 2020 | $952,000 | +5.9% | 10,000 | 0.0% | 0.18% | -13.1% |
| Q1 2020 | $899,000 | +69.6% | 10,000 | 0.0% | 0.21% | +128.9% |
| Q4 2019 | $530,000 | +34.2% | 10,000 | 0.0% | 0.09% | +25.0% |
| Q3 2019 | $395,000 | +59.9% | 10,000 | +66.7% | 0.07% | +63.6% |
| Q2 2019 | $247,000 | -11.8% | 6,000 | 0.0% | 0.04% | -13.7% |
| Q1 2019 | $280,000 | -8.2% | 6,000 | -14.3% | 0.05% | -20.3% |
| Q4 2018 | $305,000 | -23.9% | 7,000 | 0.0% | 0.06% | -5.9% |
| Q3 2018 | $401,000 | +17.9% | 7,000 | 0.0% | 0.07% | +11.5% |
| Q2 2018 | $340,000 | +24.1% | 7,000 | 0.0% | 0.06% | +24.5% |
| Q1 2018 | $274,000 | -7.7% | 7,000 | 0.0% | 0.05% | -3.9% |
| Q4 2017 | $297,000 | +13.8% | 7,000 | 0.0% | 0.05% | +8.5% |
| Q3 2017 | $261,000 | +22.5% | 7,000 | 0.0% | 0.05% | +17.5% |
| Q2 2017 | $213,000 | -16.1% | 7,000 | 0.0% | 0.04% | -24.5% |
| Q3 2016 | $254,000 | +6.7% | 7,000 | 0.0% | 0.05% | +3.9% |
| Q2 2016 | $238,000 | +6.7% | 7,000 | 0.0% | 0.05% | +8.5% |
| Q1 2016 | $223,000 | -34.8% | 7,000 | 0.0% | 0.05% | -32.9% |
| Q4 2015 | $342,000 | +54.8% | 7,000 | 0.0% | 0.07% | +62.8% |
| Q2 2015 | $221,000 | -17.2% | 7,000 | 0.0% | 0.04% | -17.3% |
| Q1 2015 | $267,000 | -2.2% | 7,000 | 0.0% | 0.05% | -1.9% |
| Q4 2014 | $273,000 | +28.8% | 7,000 | 0.0% | 0.05% | +23.3% |
| Q3 2014 | $212,000 | -10.9% | 7,000 | 0.0% | 0.04% | -8.5% |
| Q2 2014 | $238,000 | -1.2% | 7,000 | 0.0% | 0.05% | -6.0% |
| Q1 2014 | $241,000 | – | 7,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,449,300 | $59,537,000,000 | 6.61% |
| Foresite Capital Management II, LLC | 188,602 | $7,748,000 | 4.36% |
| Foresite Capital Management III, LLC | 254,923 | $10,472,000 | 3.43% |
| Artal Group S.A. | 1,500,000 | $61,620,000 | 2.49% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,305,174 | $53,617,000 | 1.93% |
| Asymmetry Capital Management, L.P. | 82,473 | $3,388,000 | 1.84% |
| QVT Financial LP | 190,977 | $7,845,000 | 1.66% |
| SECTORAL ASSET MANAGEMENT INC | 269,396 | $11,067,000 | 1.32% |
| Sofinnova Investments, Inc. | 241,043 | $9,902,000 | 0.91% |
| Novo Holdings A/S | 119,708 | $4,918,000 | 0.69% |